Abstract

3094Background: LTX-315 disintegrates cytoplasmic organelles and induces immunogenic cell death and systemic immune responses preclinically. Systemic efficacy can be enhanced in vivo by combination...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
560 Immunotherapeutic and antimetastatic activity of LTX-315 in preclinical models of ICI-resistant breast cancer
Takahiro Yamazaki ... Baldur Sveinbjornsson
Journal for ImmunoTherapy of Cancer | VOL. 9
Takahiro Yamazaki, et. al.Takahiro Yamazaki ... Baldur Sveinbjornsson
01 Nov 2021
Abstract CT069: A Phase I study of the oncolytic peptide LTX-315 generates de novo T-cell responses and clinical benefit in patients with advanced melanoma
Aurelien Marabelle ... James Spicer
American Journal of Cancer | VOL. 79
Aurelien Marabelle, et. al.Aurelien Marabelle ... James Spicer
01 Jul 2019
Abstract CT010: A phase I study of the oncolytic peptide LTX-315 generatesde novoT-cell responses and clinical benefit in patients with advanced sarcoma
Jean-Francois Baaurain ... Jerome Galon
American Journal of Cancer | VOL. 79
Jean-Francois Baaurain, et. al.Jean-Francois Baaurain ... Jerome Galon
01 Jul 2019
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial.
Michael Friedlander ... Tarek Meniawy
Lancet Oncology | VOL. 20
Michael Friedlander, et. al.Michael Friedlander ... Tarek Meniawy
01 Aug 2019
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
It Mattered Later: A Patient-Turned-Doctor's Perspective on Fertility Loss.
Margaret Cupit-Link
Journal of Clinical Oncology | VOL. -
Margaret Cupit-LinkMargaret Cupit-Link
23 Jul 2024
At the Crossroads of Local and Systemic Treatment of Operable Non-Small Cell Lung Cancer.
Rafal Dziadziuszko ... Witold Rzyman
Journal of Clinical Oncology | VOL. -
Rafal Dziadziuszko, et. al.Rafal Dziadziuszko ... Witold Rzyman
23 Jul 2024
Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Recommendation Update.
Megan E Daly ...
Journal of Clinical Oncology | VOL. -
Megan E Daly, et. al.Megan E Daly ...
23 Jul 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
Connor Lynch ... Ralph R Weichselbaum
Journal of Clinical Oncology | VOL. -
Connor Lynch, et. al.Connor Lynch ... Ralph R Weichselbaum
22 Jul 2024
View more papers